All companies
Visit website
Mycocycle
OperatingMycocycle, Inc.
Biotech · Founded 2020
Converting Waste Streams into Value
Post-money valuation ⓘ
$7.5M
As of May 2021 · from Mycocycle Stock 1 · pre-money + amount raised, not a traded price
Total raised
$507,773
Across 1 round since 2020
Latest share price
$1.75
Mycocycle Stock 1 offering price
Financials
FY2018–FY2025 · from SEC filings · hover any figure for its source$0
−$34K
2018
$0
−$76K
2019
$18K
−$9K
2020
$29K
−$347K
2021
$61K
−$615K
2022
$147K
−$1.3M
2023
$709K
−$2.6M
2024
$499K
−$3.7M
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$0
$0
$18,399
$28,695
$61,328
$147,159
$708,776
$499,165
Cost of goods sold
$0
$0
$1,600
$4,756
$0
$127,324
$309,054
$625,913
Gross margin
—
—
91%
83%
100%
13%
56%
-25%
Net income
-$34,000
-$76,226
-$8,761
-$347,093
-$614,531
-$1,285,614
-$2,629,622
-$3,675,584
Taxes paid
$0
$0
$0
$0
$0
$0
$0
$0
Balance sheet
Cash
$0
$0
$20,000
$0
$1,767,551
$411,268
$1,848,911
$1,085,059
Accounts receivable
$0
$0
$20,000
$0
$10,970
$0
$0
$74,368
Total assets
$0
$11,964
-$8,761
$145,982
$1,778,522
$502,027
$1,932,744
$1,166,426
Short-term debt
$0
$0
$0
$4,074
$1,781
$52,320
$139,651
$155,126
Long-term debt
$0
$0
$0
$55,003
$32,810
$24,873
$0
$655,126
Total liabilities
$0
$0
$0
$59,077
$34,591
$77,193
$139,651
$810,252
Other
Headcount
—
1
—
4
7
9
14
10
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$7.5M
post-money
Mycocycle Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $507.8K / $945.5KInvestors 632Post-money $7.5M
Reg CF annual-report compliance
Not required3+ reports filed & assets ≤ $10M
Filed 5 of 6 annual reports (FY2020–FY2025)
632 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 12 filings on EDGARSource: ManualCIK 0001831805Share price $1.75
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.